Humasis (Korea) Performance
| 205470 Stock | KRW 1,593 19.00 1.18% |
The company retains a Market Volatility (i.e., Beta) of 0.45, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Humasis' returns are expected to increase less than the market. However, during the bear market, the loss of holding Humasis is expected to be smaller as well. At this point, Humasis has a negative expected return of -0.0576%. Please make sure to check out Humasis' coefficient of variation, jensen alpha, treynor ratio, as well as the relationship between the standard deviation and total risk alpha , to decide if Humasis performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Humasis Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Humasis is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Total Cashflows From Investing Activities | -31.4 B |
Humasis |
Humasis Relative Risk vs. Return Landscape
If you would invest 168,400 in Humasis Co on December 21, 2024 and sell it today you would lose (9,100) from holding Humasis Co or give up 5.4% of portfolio value over 90 days. Humasis Co is generating negative expected returns and assumes 2.9975% volatility on return distribution over the 90 days horizon. Simply put, 26% of stocks are less volatile than Humasis, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Humasis Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Humasis' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Humasis Co, and traders can use it to determine the average amount a Humasis' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0192
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 205470 |
Estimated Market Risk
| 3.0 actual daily | 26 74% of assets are more volatile |
Expected Return
| -0.06 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Humasis is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Humasis by adding Humasis to a well-diversified portfolio.
Humasis Fundamentals Growth
Humasis Stock prices reflect investors' perceptions of the future prospects and financial health of Humasis, and Humasis fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Humasis Stock performance.
| Return On Equity | 117.34 | |||
| Return On Asset | 0.41 | |||
| Profit Margin | 0.48 % | |||
| Operating Margin | 0.58 % | |||
| Current Valuation | 603.35 B | |||
| Shares Outstanding | 27.69 M | |||
| Price To Sales | 7.74 X | |||
| Revenue | 321.83 B | |||
| EBITDA | 38.07 B | |||
| Cash And Equivalents | 176.58 B | |||
| Cash Per Share | 962.18 X | |||
| Total Debt | 2.25 B | |||
| Debt To Equity | 0.18 % | |||
| Cash Flow From Operations | 205.02 B | |||
| Total Asset | 340.71 B | |||
About Humasis Performance
By analyzing Humasis' fundamental ratios, stakeholders can gain valuable insights into Humasis' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Humasis has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Humasis has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Ltd. develops, manufactures, and markets in-vitro diagnostics for the detection of cardiac marker, fertility hormone, infectious disease, tumor marker, and cotinine for home and laboratory use in South Korea and internationally. The company was founded in 2000 and is based in Anyang, South Korea. HUMASIS is traded on Korean Securities Dealers Automated Quotations in South Korea.Things to note about Humasis performance evaluation
Checking the ongoing alerts about Humasis for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Humasis help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Humasis generated a negative expected return over the last 90 days |
- Analyzing Humasis' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Humasis' stock is overvalued or undervalued compared to its peers.
- Examining Humasis' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Humasis' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Humasis' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Humasis' stock. These opinions can provide insight into Humasis' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Humasis Stock analysis
When running Humasis' price analysis, check to measure Humasis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Humasis is operating at the current time. Most of Humasis' value examination focuses on studying past and present price action to predict the probability of Humasis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Humasis' price. Additionally, you may evaluate how the addition of Humasis to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |